ATE489098T1 - Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen - Google Patents

Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen

Info

Publication number: ATE489098T1
Authority: AT; Austria
Prior art keywords: ointment; pharmaceutical composition; active ingredients; dissolved active; pharmaceutical
Prior art date: 2004-06-17

Application number

AT05777135T

Other languages

English (en)

Inventor

Leslie Zanutto

Sandrine Orsoni

Nathalie Barthez

Original Assignee

Galderma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-17

Filing date

2005-06-15

Publication date

2010-12-15

2005-06-15 Application filed by Galderma Sa filed Critical Galderma Sa

2010-12-15 Application granted granted Critical

2010-12-15 Publication of ATE489098T1 publication Critical patent/ATE489098T1/de

Links

239000002674 ointment Substances 0.000 title abstract 2
239000004480 active ingredient Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
201000004681 Psoriasis Diseases 0.000 abstract 1
GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 abstract 1
229960005084 calcitriol Drugs 0.000 abstract 1
235000020964 calcitriol Nutrition 0.000 abstract 1
239000011612 calcitriol Substances 0.000 abstract 1
229960004703 clobetasol propionate Drugs 0.000 abstract 1
CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 abstract 1
230000002209 hydrophobic effect Effects 0.000 abstract 1
230000035515 penetration Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT05777135T 2004-06-17 2005-06-15 Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen ATE489098T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0406609A FR2871694B1 (fr)	2004-06-17	2004-06-17	Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
PCT/FR2005/001493 WO2006005842A1 (fr)	2004-06-17	2005-06-15	Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises.

Publications (1)

Publication Number	Publication Date
ATE489098T1 true ATE489098T1 (de)	2010-12-15

Family

ID=34946515

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05777135T ATE489098T1 (de)	2004-06-17	2005-06-15	Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen

Country Status (14)

Country	Link
US (1)	US20050281848A1 (de)
EP (1)	EP1758588B1 (de)
JP (1)	JP2008502661A (de)
CN (1)	CN101090725A (de)
AT (1)	ATE489098T1 (de)
AU (1)	AU2005261569A1 (de)
BR (1)	BRPI0511206A (de)
CA (1)	CA2567680A1 (de)
DE (1)	DE602005024959D1 (de)
ES (1)	ES2360469T3 (de)
FR (1)	FR2871694B1 (de)
MX (1)	MXPA06014407A (de)
RU (1)	RU2007101516A (de)
WO (1)	WO2006005842A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2885527B1 (fr) *	2005-05-16	2007-06-29	Galderma Res & Dev	Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise
BRPI0715636A2 (pt) *	2006-08-29	2013-07-02	Teva Pharma	composiÇÕes farmacologicamente ativas estÁveis incluindo compostos contendo vitamina d e corticosteràide com compatibilidade para ph baixo
FR2909284B1 (fr) *	2006-11-30	2012-09-21	Galderma Sa	Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
FR2912655A1 (fr) *	2007-02-15	2008-08-22	Galderma Sa	Produit de soin cutane a double compartiment comprenant du calcitriol et du propionate de clobetasol, et son utilisation
US10265265B2 (en) *	2007-03-15	2019-04-23	Drug Delivery Solutions Limited	Topical composition
EP1970048A1 (de) *	2007-03-15	2008-09-17	Drug Delivery Solutions Limited	Polyaphron topische Zusammensetzung mit Vitamin D
EP2008651A1 (de)	2007-06-26	2008-12-31	Drug Delivery Solutions Limited	Biologisch erodierbares Patch
US20120004200A1 (en) *	2008-12-23	2012-01-05	Galderma S.A.	Topical pharmaceutical composition containing a water-sensitive active principle
RU2560677C2 (ru) *	2009-12-22	2015-08-20	Лео Фарма А/С	Кожная композиция, включающая аналог витамина d и смесь растворителя и поверхностно-активных веществ
MX2012007225A (es) *	2009-12-22	2012-07-30	Leo Pharma As	Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d.
US9610245B2 (en)	2011-03-14	2017-04-04	Drug Delivery Solutions Limited	Ophthalmic composition
CN104666312B (zh) *	2015-02-12	2017-11-07	重庆华邦制药有限公司	含有卡泊三醇和二丙酸倍他米松的制剂
CN108969527B (zh) *	2017-05-31	2021-05-11	上海通用药业股份有限公司	一种药物制剂及其制备方法和用途
EP3542788A1 (de)	2018-03-19	2019-09-25	MC2 Therapeutics Limited	Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1272953A (en) *	1984-10-08	1990-08-21	Yuji Makino	Pharmaceutical composition for external use containing active-type vitamin d.sub.3
US5185150A (en) *	1990-08-24	1993-02-09	Wisconsin Alumni Research Fdn.	Cosmetic compositions containing 19-nor-vitamin D compounds
CN1173703C (zh) *	1999-04-23	2004-11-03	里奥药物制品有限公司	药物组合物
WO2002034235A1 (en) *	2000-10-27	2002-05-02	Leo Pharma A/S	Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
PL374777A1 (en) *	2002-12-17	2005-10-31	Galderma Sa	Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
FR2848454B1 (fr) *	2002-12-17	2007-03-30	Galderma Res & Dev	Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
US7582307B2 (en) *	2003-11-26	2009-09-01	Harmony Labs, Inc.	Dermatological composition

2004
- 2004-06-17 FR FR0406609A patent/FR2871694B1/fr not_active Expired - Fee Related
- 2004-10-07 US US10/959,431 patent/US20050281848A1/en not_active Abandoned
2005
- 2005-06-15 CA CA002567680A patent/CA2567680A1/fr not_active Abandoned
- 2005-06-15 BR BRPI0511206-0A patent/BRPI0511206A/pt not_active Application Discontinuation
- 2005-06-15 ES ES05777135T patent/ES2360469T3/es not_active Expired - Lifetime
- 2005-06-15 CN CNA2005800200365A patent/CN101090725A/zh active Pending
- 2005-06-15 RU RU2007101516/15A patent/RU2007101516A/ru unknown
- 2005-06-15 AU AU2005261569A patent/AU2005261569A1/en not_active Abandoned
- 2005-06-15 DE DE602005024959T patent/DE602005024959D1/de not_active Expired - Lifetime
- 2005-06-15 JP JP2007515996A patent/JP2008502661A/ja not_active Withdrawn
- 2005-06-15 AT AT05777135T patent/ATE489098T1/de not_active IP Right Cessation
- 2005-06-15 EP EP05777135A patent/EP1758588B1/de not_active Expired - Lifetime
- 2005-06-15 WO PCT/FR2005/001493 patent/WO2006005842A1/fr not_active Ceased
- 2005-06-15 MX MXPA06014407A patent/MXPA06014407A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
ES2360469T3 (es)	2011-06-06
CA2567680A1 (fr)	2006-01-19
EP1758588B1 (de)	2010-11-24
BRPI0511206A (pt)	2007-11-27
CN101090725A (zh)	2007-12-19
EP1758588A1 (de)	2007-03-07
RU2007101516A (ru)	2008-07-27
DE602005024959D1 (de)	2011-01-05
WO2006005842A1 (fr)	2006-01-19
FR2871694B1 (fr)	2008-07-04
US20050281848A1 (en)	2005-12-22
AU2005261569A1 (en)	2006-01-19
MXPA06014407A (es)	2007-02-19
FR2871694A1 (fr)	2005-12-23
JP2008502661A (ja)	2008-01-31

Similar Documents

Publication	Publication Date	Title
DE602005024959D1 (de)	2011-01-05	Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen
DK1545619T3 (da)	2008-05-26	Oplösning til ungual påföring
CL2009000393A1 (es)	2010-01-04	Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
MY137060A (en)	2008-12-31	Topical pharmaceutical compositions comprising proanthocyanidins, glycyrrhetinic acid and telmesteine for the treatment of dermatitis
PT939627E (pt)	2004-02-27	Pentafluorobenzenossulfonamidas e analogos
BRPI0714399B8 (pt)	2021-05-25	composição farmacêutica líquida oral
ECSP045407A (es)	2005-01-03	Benzazoles sustituidos y el uso del mismo como inhibidores de quinasa raf
CY1111742T1 (el)	2015-10-07	Πολυδυναμες συνθεσεις υψηλου φορτιου συμπυκνωματος για τον ελεγχο εκτοπαρασιτων
ATE275393T1 (de)	2004-09-15	Feste dispersionen mit nitrataktiven wirkstoffen
PA8748101A1 (es)	2009-08-26	Benzoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus
DE60322412D1 (de)	2008-09-04	Pharmazeutische feste Dispersionen von Modafinil-Verbindungen
CY1109507T1 (el)	2014-08-13	Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια
AU2001234273A1 (en)	2001-08-20	Thiazolopyrimidines and their use as modulators of chemokine receptor activity
CY1109541T1 (el)	2014-08-13	Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ
MX2009004295A (es)	2009-05-05	Uso de un acido indazolmetoxialcanoico para reducir niveles de triglicerido, colesterol y glucosa.
Hua et al.	2014	Potent tumor targeting drug release system comprising MMP-2 specific peptide fragment with self-assembling characteristics
DE60316724D1 (de)	2007-11-15	Pharmazeutische zusammensetzung enthaltend calcitriol und clobetasol propionate
ATE414092T1 (de)	2008-11-15	Phosphoindole als hiv-inhibitoren
DE60003188D1 (de)	2003-07-10	Paracetamol und drotaverin enthaltende zusammensetzung
DE602004017164D1 (de)	2008-11-27	Albuminkonjugate, die eine Glucuron-Verknüpfung enthalten
UY26473A1 (es)	2001-06-29	Compuestos activos en el receptor de glucocorticoide
AR045178A1 (es)	2005-10-19	Uso de un componente retinoide seleccionado entre el grupo formado por agentes retinoides activos, precursores de agentes retinoides activos y mezclas de los mismos, para preparar una composicion farmaceutica
WO2006076119A3 (en)	2006-08-31	Treatment of skin diseases
RU2020113986A (ru)	2021-10-04	Назальная мазь для профилактики в период эпидемии
BR0215498A (pt)	2004-12-28	Composição farmacêutica compreendendo uma glitazona e um ácido 4-oxobutanóico e o seu uso para o tratamento de diabetes

Legal Events

Date	Code	Title	Description
2011-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties